Cargando…
Clinical Impact of Psychopathy on Bipolar Disorder
Background and Objectives. Bipolar disorder (BD) is associated with a significant burden due to affective symptoms and behavioral manifestations, but also cognitive and functional impairment. Comorbidity with other psychiatric conditions, including personality disorders, is frequent. The comorbidity...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918117/ https://www.ncbi.nlm.nih.gov/pubmed/33673356 http://dx.doi.org/10.3390/medicina57020165 |
_version_ | 1783657855046385664 |
---|---|
author | Calabrò, Giuseppina Musolino, Antonio Francesco Filippo, Andrea Adolfo de Filippis, Renato Carbone, Elvira Anna Rania, Marianna Aloi, Matteo Pugliese, Valentina Segura-Garcia, Cristina |
author_facet | Calabrò, Giuseppina Musolino, Antonio Francesco Filippo, Andrea Adolfo de Filippis, Renato Carbone, Elvira Anna Rania, Marianna Aloi, Matteo Pugliese, Valentina Segura-Garcia, Cristina |
author_sort | Calabrò, Giuseppina |
collection | PubMed |
description | Background and Objectives. Bipolar disorder (BD) is associated with a significant burden due to affective symptoms and behavioral manifestations, but also cognitive and functional impairment. Comorbidity with other psychiatric conditions, including personality disorders, is frequent. The comorbidity with psychopathy deserves special consideration given that both disorders share some clinical characteristics, such as grandiosity, risky behavior or poor insight, among others, that can worsen the outcome of BD. Therefore, this study aimed to evaluate the prevalence of psychopathy in a sample of clinically stabilized patients with BD and its impact on the severity of BD. Materials and Methods. A sample of 111 patients with BD (38 type I and 73 type II) was studied. The Hamilton Depression Rating Scale (HAM-D) and the Young Mania Rating Scale (YMRS) served to assess the severity of BD. Psychopathy was measured by means of the Psychopathic Personality Inventory-Revised (PPI-R). Patients were divided into three groups according to the severity of psychopathy (Group 1: no psychopathy; Group 2: “psychopathic” trait; Group 3: clinical psychopathy). Other measures regarded impulsiveness (Barratt Impulsiveness Scale-11, BIS-11) and empathy (Empathy Quotient, EQ). Comparisons of mania, depression, impulsivity and empathy scores were run with MANOVA considering psychopathy and diagnosis as independent variables. Results. The prevalence of psychopathy was 5.4%. A significant association between the level of psychopathy and YMRS, attentional/cognitive impulsivity and motor impulsivity scores emerged. No interaction between psychopathy and BD diagnosis was found. Post hoc analysis demonstrated significantly higher YMRS scores in Group 3 than in Group 1; that is, patients with psychopathy have more manic symptoms. Conclusion. Psychopathy seems quite frequent among patients with BD. The association of psychopathy with BD results in higher impulsivity and manic symptoms. In light of this, psychopathy should be investigated when assessing patients with BD, regardless of the comorbidity of BD with other personality disorders. |
format | Online Article Text |
id | pubmed-7918117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79181172021-03-02 Clinical Impact of Psychopathy on Bipolar Disorder Calabrò, Giuseppina Musolino, Antonio Francesco Filippo, Andrea Adolfo de Filippis, Renato Carbone, Elvira Anna Rania, Marianna Aloi, Matteo Pugliese, Valentina Segura-Garcia, Cristina Medicina (Kaunas) Article Background and Objectives. Bipolar disorder (BD) is associated with a significant burden due to affective symptoms and behavioral manifestations, but also cognitive and functional impairment. Comorbidity with other psychiatric conditions, including personality disorders, is frequent. The comorbidity with psychopathy deserves special consideration given that both disorders share some clinical characteristics, such as grandiosity, risky behavior or poor insight, among others, that can worsen the outcome of BD. Therefore, this study aimed to evaluate the prevalence of psychopathy in a sample of clinically stabilized patients with BD and its impact on the severity of BD. Materials and Methods. A sample of 111 patients with BD (38 type I and 73 type II) was studied. The Hamilton Depression Rating Scale (HAM-D) and the Young Mania Rating Scale (YMRS) served to assess the severity of BD. Psychopathy was measured by means of the Psychopathic Personality Inventory-Revised (PPI-R). Patients were divided into three groups according to the severity of psychopathy (Group 1: no psychopathy; Group 2: “psychopathic” trait; Group 3: clinical psychopathy). Other measures regarded impulsiveness (Barratt Impulsiveness Scale-11, BIS-11) and empathy (Empathy Quotient, EQ). Comparisons of mania, depression, impulsivity and empathy scores were run with MANOVA considering psychopathy and diagnosis as independent variables. Results. The prevalence of psychopathy was 5.4%. A significant association between the level of psychopathy and YMRS, attentional/cognitive impulsivity and motor impulsivity scores emerged. No interaction between psychopathy and BD diagnosis was found. Post hoc analysis demonstrated significantly higher YMRS scores in Group 3 than in Group 1; that is, patients with psychopathy have more manic symptoms. Conclusion. Psychopathy seems quite frequent among patients with BD. The association of psychopathy with BD results in higher impulsivity and manic symptoms. In light of this, psychopathy should be investigated when assessing patients with BD, regardless of the comorbidity of BD with other personality disorders. MDPI 2021-02-12 /pmc/articles/PMC7918117/ /pubmed/33673356 http://dx.doi.org/10.3390/medicina57020165 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Calabrò, Giuseppina Musolino, Antonio Francesco Filippo, Andrea Adolfo de Filippis, Renato Carbone, Elvira Anna Rania, Marianna Aloi, Matteo Pugliese, Valentina Segura-Garcia, Cristina Clinical Impact of Psychopathy on Bipolar Disorder |
title | Clinical Impact of Psychopathy on Bipolar Disorder |
title_full | Clinical Impact of Psychopathy on Bipolar Disorder |
title_fullStr | Clinical Impact of Psychopathy on Bipolar Disorder |
title_full_unstemmed | Clinical Impact of Psychopathy on Bipolar Disorder |
title_short | Clinical Impact of Psychopathy on Bipolar Disorder |
title_sort | clinical impact of psychopathy on bipolar disorder |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918117/ https://www.ncbi.nlm.nih.gov/pubmed/33673356 http://dx.doi.org/10.3390/medicina57020165 |
work_keys_str_mv | AT calabrogiuseppina clinicalimpactofpsychopathyonbipolardisorder AT musolinoantoniofrancesco clinicalimpactofpsychopathyonbipolardisorder AT filippoandreaadolfo clinicalimpactofpsychopathyonbipolardisorder AT defilippisrenato clinicalimpactofpsychopathyonbipolardisorder AT carboneelviraanna clinicalimpactofpsychopathyonbipolardisorder AT raniamarianna clinicalimpactofpsychopathyonbipolardisorder AT aloimatteo clinicalimpactofpsychopathyonbipolardisorder AT pugliesevalentina clinicalimpactofpsychopathyonbipolardisorder AT seguragarciacristina clinicalimpactofpsychopathyonbipolardisorder |